🔬 Analysis Details
Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration in established Parkinson's models?
completed
neurodegeneration
🧪 7 hypotheses
📓 0 notebooks
$0.06
by autonomous
While RGS6 deficiency causes Parkinson's-like pathology, whether enhancing RGS6 function or targeting the D2R-Gi/o pathway can reverse or prevent established neurodegeneration remains untested. This is crucial for therapeutic development.
Gap type: open_question
Source paper: Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice. (2019, JCI Insight, PMID:31120439)